Literature DB >> 1705

Elevated levels of immunoglobulin E in the acute febrile mucocutaneous lymph node syndrome.

S Kusakawa, D C Heiner.   

Abstract

Mucocutaneous lymph node syndrome (MCLS) is a newly recognized disease characterized by fever persisting for more than 5 days, an erythematous skin eruption, conjunctival congestion, dry red fissured lips, reddened tongue, palms, and soles, nonpurulent lymphadenopathy, and sometines diarrhea, arthralgia, and aseptic meningitis. Additional features may include carditis, pericarditis, aneurysmal dilation and thrombosis of coronary arteries, and sudden death. There is a striking similarity of fatal cases to infantile polyarteritis nodosa, a disease recently reported to be associated with elevated levels of serium IgE. Indeed, it is likely that MCLS represents a disease which can progress to polyarteritis nodosa in infants and young children. The paired acute and convalescent serum IgE levels of 20 subjects with acute nonfatal MCLS were studied along with 20 near-age unaffected controls from the same communities in Japan. The results indicate that most if not all subjects with MCLS in the study had an elevation of total serum IgE during the acute phase of the disease (geometric mean 157 IU/ml compared with the control value of 38 IU/ml, P = 0.005). The level appeared to reach a peak 1-2 weeks after onset and declined over the ensuing 1-2 months.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1705     DOI: 10.1203/00006450-197602000-00007

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  19 in total

1.  Antibodies to native type III collagen in the serum of patients with Kawasaki disease.

Authors:  S Kobayashi; N Wada; M Kubo
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

2.  Allergy-epitomes of progress: mucocutaneous lymph node syndrome.

Authors:  D C Heiner
Journal:  West J Med       Date:  1977-11

Review 3.  Control of IgE synthesis in man.

Authors:  D Y Leung; R S Geha
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

4.  Inhibition of lymphocyte DNA synthesis by plasma from patients with Kawasaki disease.

Authors:  J Hirao; N Izumi; Y Nagai; N Homma
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

5.  Kawasaki's disease.

Authors:  C L Berry
Journal:  Pediatr Cardiol       Date:  1983 Jul-Sep       Impact factor: 1.655

6.  Immunological studies on Kawasaki disease: II. Isolation and characterization of an immunosuppressive factor in acute phase sera.

Authors:  J Hirao; N Yoshimura; N Homma; K Kano
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

7.  Immunological studies on Kawasaki disease. I. Appearance of Hanganutziu-Deicher antibodies.

Authors:  M Takiguchi; T Tamura; M Goto; S Kusakawa; F Milgrom; K Kano
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

8.  Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective.

Authors:  Mariah B Pate; John Kelly Smith; David S Chi; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2010-02-23

9.  Mucocutaneous lymph node syndrome with necrotic pharyngitis.

Authors:  L Brion; M Courtoy; D Bachelart; H Szliwowski; M Dickstein; M Heenen; M Tondeur
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

10.  Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. A skin biopsy study of 27 patients.

Authors:  S Hirose; Y Hamashima
Journal:  Eur J Pediatr       Date:  1978-08-17       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.